theophylline has been researched along with Acute Symptom Flare in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "COPD is characterized by chronic inflammation." | 2.82 | Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial. ( Agusti, A; Barnes, PJ; Córdova, R; Cosío, BG; Gea, J; Iglesias, A; Palou, A; Pascual, S; Peces-Barba, G; Rodriguez-Roisin, R; Shafiek, H; Sibila, O; Yanez, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosío, BG | 1 |
| Shafiek, H | 1 |
| Iglesias, A | 1 |
| Yanez, A | 1 |
| Córdova, R | 1 |
| Palou, A | 1 |
| Rodriguez-Roisin, R | 1 |
| Peces-Barba, G | 1 |
| Pascual, S | 1 |
| Gea, J | 1 |
| Sibila, O | 1 |
| Barnes, PJ | 1 |
| Agusti, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter 52 Weeks Double Blind Placebo-controlled Trial for the Assessment of Theophylline on Top of Combination Therapy in Severe COPD[NCT01599871] | Phase 3 | 70 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for theophylline and Acute Symptom Flare
| Article | Year |
|---|---|
Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Anti | 2016 |